IRIS UniCatt

Schinzari, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.835
AS - Asia 3.145
EU - Europa 2.841
SA - Sud America 540
AF - Africa 103
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.485
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.705
SG - Singapore 1.461
DE - Germania 616
CN - Cina 597
SE - Svezia 502
BR - Brasile 444
IT - Italia 397
VN - Vietnam 386
NL - Olanda 352
FR - Francia 249
IN - India 176
GB - Regno Unito 141
IE - Irlanda 120
FI - Finlandia 96
HK - Hong Kong 86
JP - Giappone 80
PL - Polonia 80
ID - Indonesia 77
UA - Ucraina 74
CA - Canada 67
RU - Federazione Russa 52
BD - Bangladesh 51
TR - Turchia 49
MX - Messico 42
CI - Costa d'Avorio 39
ES - Italia 34
AR - Argentina 33
IQ - Iraq 32
AT - Austria 24
BE - Belgio 24
KR - Corea 23
ZA - Sudafrica 21
IR - Iran 17
EC - Ecuador 16
AU - Australia 15
CZ - Repubblica Ceca 15
CO - Colombia 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
RO - Romania 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
MA - Marocco 11
PK - Pakistan 11
JO - Giordania 10
EG - Egitto 8
IL - Israele 8
PE - Perù 7
PH - Filippine 7
AL - Albania 6
AZ - Azerbaigian 6
CH - Svizzera 6
CL - Cile 6
HR - Croazia 5
LT - Lituania 5
NP - Nepal 5
SN - Senegal 5
DZ - Algeria 4
GR - Grecia 4
JM - Giamaica 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
PA - Panama 4
PT - Portogallo 4
UY - Uruguay 4
CY - Cipro 3
ET - Etiopia 3
EU - Europa 3
KE - Kenya 3
LU - Lussemburgo 3
NO - Norvegia 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
UG - Uganda 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
IS - Islanda 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
Totale 10.471
Salva come PNG Salva come JPEG
Città #
Singapore 893
Chandler 481
Ashburn 368
San Jose 362
Amsterdam 340
New York 137
Ho Chi Minh City 136
Los Angeles 134
Beijing 124
Dublin 119
Hanoi 100
Rome 95
Lauterbourg 84
Hong Kong 78
Frankfurt am Main 77
Tokyo 75
The Dalles 74
Jakarta 73
Warsaw 73
Hyderabad 71
Wilmington 70
Hefei 66
Dallas 65
San Mateo 63
St Louis 59
Ann Arbor 56
Fairfield 56
Helsinki 55
Milan 53
Munich 52
São Paulo 51
Boston 46
Princeton 46
Chicago 45
Nanjing 44
Jacksonville 42
Abidjan 39
Marseille 39
Houston 37
Dearborn 35
Santa Clara 35
North Bergen 34
Cattolica 33
Council Bluffs 32
London 32
Moscow 31
Orem 31
Seattle 31
Falkenstein 26
Redwood City 26
Nürnberg 25
Woodbridge 25
Brussels 24
Cambridge 24
Redmond 24
Brooklyn 23
Nuremberg 23
Seoul 22
Buffalo 21
Kent 21
Bremen 20
Denver 19
Mexico City 19
Montreal 19
Shanghai 19
Boardman 18
Da Nang 18
Phoenix 18
Atlanta 17
Izmir 17
Nanchang 17
Chennai 16
Toronto 16
Haiphong 15
Rio de Janeiro 15
Stockholm 15
Falls Church 14
Guangzhou 14
Manchester 14
Paris 14
Lappeenranta 13
Turku 13
Augusta 12
Hebei 12
Mumbai 12
Norwalk 11
San Francisco 11
Vienna 11
Amman 10
Changsha 10
Düsseldorf 10
Johannesburg 10
Lawrence 10
Leawood 10
Poplar 10
Ankara 9
Washington 9
Belo Horizonte 8
Charlotte 8
City of London 8
Totale 5.997
Salva come PNG Salva come JPEG
Nome #
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 500
Pembrolizumab as first-line treatment for metastatic uveal melanoma 342
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 234
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 194
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 190
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 182
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 181
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 179
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 177
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 171
Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period 164
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 160
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 158
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 157
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 156
Are TKIs favourable for the elderly with non-small-cell lung cancer? 155
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 151
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 150
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 150
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 148
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 139
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 138
Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report 137
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 135
Methylation study of the Paris system for reporting urinary (TPS) categories 134
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 131
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 131
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 130
Skin cancer triage and management during COVID-19 pandemic. 129
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 128
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 128
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 128
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review 125
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 125
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 125
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study 124
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 124
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 124
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 123
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 121
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 121
Biomarkers of response to advanced prostate cancer therapy 121
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 120
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 118
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 117
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 117
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 116
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 111
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 111
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 110
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 109
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 108
Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors 105
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 105
The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review 105
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 104
Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy 103
Efficacy of immune checkpoint inhibitors in different types of melanoma 103
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 103
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway 102
The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review 102
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 99
Unconventional radiotherapy to enhance immunotherapy efficacy in bulky tumors: a case report 96
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 95
The Role of Multidisciplinary Ocular and Periocular Cancers Meetings in Uveal Melanoma Management: A 2-Year Analysis 94
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 94
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 93
Line-Field Confocal Optical Coherence Tomography Evaluation of Eyelid Skin Lesions 92
Atypical Presentation of Splenic Tissue Mimicking Neuroendocrine Tumor Relapse 89
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. 87
A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients 86
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment 81
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer 80
“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management 80
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial 75
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 74
Targeted therapy in advanced gastric carcinoma: The future is beginning 73
Direct effects of GnRH agonists in human hormone-sensitive endometrial cells 73
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 65
Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. 61
Impact of en bloc extended R0 resections on oncological outcome of locally advanced adrenocortical carcinoma 57
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration-resistant prostate cancer treated with 223Radium 52
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study 49
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis 47
Is 18F-fluorodeoxyglucose the tracer of choice for functional imaging of neuroendocrine tumors grade 3? A case report 45
Totale 10.626
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.026
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 0 50 4
2021/2022636 59 18 15 99 39 14 13 86 33 43 95 122
2022/20231.381 181 178 100 226 57 158 103 121 143 32 59 23
2023/2024762 35 169 47 41 31 111 52 33 14 34 106 89
2024/20251.737 35 54 124 70 144 71 70 59 232 210 321 347
2025/20264.809 598 123 271 628 835 561 936 262 306 269 20 0
Totale 10.626